The effect of zanamivir treatment on the early immune response to influenza vaccinationCOX, Rebecca J; MYKKELTVEDT, Eva; SJURSEN, Hakon et al.Vaccine. 2001, Vol 19, Num 32, pp 4743-4749, issn 0264-410XArticle

Zanamivir to prevent influenza. Authors' replyFEDER, Henry M; VAN DER WOUDEN, Johannes C; VAN BENTVELD, Reinout D. W et al.The New England journal of medicine. 2001, Vol 344, Num 7, pp 528-530, issn 0028-4793Article

Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: A retrospective studyLOUGHLIN, Jeanne E; ALFREDSON, Tanya D; AJENE, Anuli N et al.Clinical therapeutics. 2002, Vol 24, Num 11, pp 1786-1799, issn 0149-2918, 14 p.Article

The effect of zanamivir treatment on influenza complications: A retrospective cohort studyCOLE, J. Alexander; LOUGHLIN, Jeanne E; AJENE, Anuli N et al.Clinical therapeutics. 2002, Vol 24, Num 11, pp 1824-1839, issn 0149-2918, 16 p.Article

Neuraminidase inhibitor resistance in influenza virusesREECE, Phillip Andrew.Journal of medical virology. 2007, Vol 79, Num 10, pp 1577-1586, issn 0146-6615, 10 p.Article

Antiviral treatment and prophylaxis of influenza in primary care: German recommendationsWUTZLER, P; KOSSOW, K.-D; LODE, H et al.Journal of clinical virology. 2004, Vol 31, Num 2, pp 84-91, issn 1386-6532, 8 p.Article

Glycochimie et thérapeutique Les inhibiteurs de neuraminidase face au risque de grippe aviaire = Neuraminidase inhibitors and risk of H5N1 influenzaGRAS-MASSE, H; WILLAND, N.Annales pharmaceutiques françaises. 2007, Vol 65, Num 1, pp 50-57, issn 0003-4509, 8 p.Conference Paper

Influenza virus resistance to neuraminidase inhibitorsSAMSON, Mélanie; PIZZORNO, Andres; ABED, Yacine et al.Antiviral research. 2013, Vol 98, Num 2, pp 174-185, issn 0166-3542, 12 p.Article

Oseltamivir―zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infectionsESCURET, Vanessa; CORNU, Catherine; GUEYFFIER, François et al.Antiviral research. 2012, Vol 96, Num 2, pp 130-137, issn 0166-3542, 8 p.Article

Les antivi raux spécifiques de la grippe: ce qu'a apporté la grippe HINI 2009CHIDIAC, Christian; FERRY, Tristan; ADER, Florence et al.MTP. Médecine thérapeutique pédiatrie. 2010, Vol 13, Num 4, pp 263-269, issn 1286-5494, 7 p.Article

A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antiviralsFERGUSON, Neil M; MALLETT, Susan; JACKSON, Helen et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 4, pp 977-990, issn 0305-7453, 14 p.Article

Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivirCASS, L. M. R; GUNAWARDENA, K. A; MACMAHON, M. M et al.Respiratory medicine. 2000, Vol 94, Num 2, pp 166-173, issn 0954-6111Article

Effect of Zanamivir on duration and resolution of influenza symptomsMONTO, Arnold S; MOULT, Andrew B; SHARP, Stephen J et al.Clinical therapeutics. 2000, Vol 22, Num 11, pp 1294-1305, issn 0149-2918Article

Bronchospasmes sous zanamivir (Relenza°) = Bronchospasms under zanamivir (Relenza°)La Revue Prescrire. 2000, Vol 20, Num 204, issn 0247-7750, p. 201Article

Prevention and treatment of influenzaCOUCH, Robert B.The New England journal of medicine. 2000, Vol 343, Num 24, pp 1778-1787, issn 0028-4793Article

The pharmacokinetics of zanamivir: a new inhaled antiviral for influenzaAOKI, Fred Y; HAYDEN, Frederick G.Clinical pharmacokinetics. 1999, Vol 36, issn 0312-5963, 66 p., SUP1Serial Issue

Zanamivir : Pas de progrès tangible contre la grippe = Zanamivir : no tangible progress against influenzaLa Revue Prescrire. 1999, Vol 19, Num 200, pp 725-728, issn 0247-7750Article

Inhibiteurs de la neuraminidase et traitement de la grippe: un bénéfice au-delà de la résolution des symptômes ? : Maladies infectieuses = Treatment of Influenza with neuraminidase inhibitors: is there a benefit beyoud symptom resolution ?KAISER, L.Médecine et hygiène. 2001, Vol 59, Num 2369, pp 2296-2300, issn 0025-6749, 3 p.Article

Grippe : vers de nouvelles possibilités thérapeutiques = New therapeutic perspectives in Myxovirus influenzae infectionBRICAIRE, F.La Presse médicale (1983). 1998, Vol 27, pp 24-26, issn 0755-4982, SUP5Conference Paper

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II StudyMARTY, Francisco M; MAN, Choy Y; ZHAO, Henry H et al.The Journal of infectious diseases. 2014, Vol 209, Num 4, pp 542-550, issn 0022-1899, 9 p.Article

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. CommentaryCOOPER, Nicola; SUTTON, Alexander J; ABRAMS, Keith R et al.BMJ. British medical journal (International ed.). 2003, Vol 326, Num 7401, pp 1235-1240, issn 0959-8146, 6 p.Article

Influenza vaccination and antiviral therapy: Is there a role for concurrent administration in the institutionalised elderly?DRINKA, Paul J.Drugs & aging. 2003, Vol 20, Num 3, pp 165-174, issn 1170-229X, 10 p.Article

Patient perspective on zanamivir in the treatment of influenzaBRICAIRE, F; COHEN, J. M; JACQUET, M et al.International journal of clinical practice (Esher). 2002, Vol 56, Num 1, pp 7-10, issn 1368-5031Article

Inhaled zanamivir for the prevention of influenza in familiesHAYDEN, Frederick G; GUBAREVA, Larisa V; MONTO, Arnold S et al.The New England journal of medicine. 2000, Vol 343, Num 18, pp 1282-1289, issn 0028-4793Article

Effectiveness and role of zanamivir in the treatment of influenza infectionSILAGY, C. A; CAMPION, K.Annals of medicine (Helsinki). 1999, Vol 31, Num 5, pp 313-317, issn 0785-3890Article